Narjoz, C.
25  Ergebnisse:
Personensuche X
?
 
?
2

Determinants of the interindividual variability in serum cy..:

Cohen, R. ; Preta, L. H. ; Joste, V....
British Journal of Clinical Pharmacology.  85 (2019)  6 - p. 1227-1238 , 2019
 
?
3

Interindividual variability in dabigatran and rivaroxaban e..:

Gouin‐Thibault, I. ; Delavenne, X. ; Blanchard, A....
Journal of Thrombosis and Haemostasis.  15 (2017)  2 - p. 273-283 , 2017
 
?
5

Relation between plasma trough concentration of abiraterone..:

Carton, E. ; Noe, G. ; Huillard, O....
European Journal of Cancer.  72 (2017)  - p. 54-61 , 2017
 
?
 
?
7

Biologie moléculaire et prise en charge des patients attein..:

Gibault, L. ; Cazes, A. ; Narjoz, C..
Revue de Pneumologie Clinique.  70 (2014)  1-2 - p. 47-62 , 2014
 
?
 
?
 
?
10

A Case of 5-FU-Related Severe Toxicity Associated with the ..:

Zaanan, A ; Dumont, L-M ; Loriot, M-A..
Clinical Pharmacology & Therapeutics.  95 (2013)  2 - p. 136-136 , 2013
 
?
11

Letter: thiopurine blood monitoring for patients with infla..:

Chouchana, L. ; Narjoz, C. ; Beaune, P...
Alimentary Pharmacology & Therapeutics.  35 (2012)  6 - p. 743-744 , 2012
 
?
12

Letter: TPMT activity and age in IBD patients – authors' re..:

Chouchana, L. ; Narjoz, C. ; Beaune, P...
Alimentary Pharmacology & Therapeutics.  35 (2012)  8 - p. 967-969 , 2012
 
?
14

Review article: the benefits of pharmacogenetics for improv..:

Chouchana, L. ; Narjoz, C. ; Beaune, P...
Alimentary Pharmacology & Therapeutics.  35 (2011)  1 - p. 15-36 , 2011
 
1-15